| Nov 23 |
Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC
|
| Nov 22 |
Layoffs in 2024: A List of Companies Cutting Jobs This Year
|
| Nov 22 |
J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis
|
| Nov 22 |
Medtronic acquires Fortimedix Surgical to boost surgical portfolio
|
| Nov 22 |
Sanofi Plans to Change Hospital Drug-Discount Program
|
| Nov 22 |
Health Canada issues NOC to J&J’s CARVYKTI for multiple myeloma
|
| Nov 22 |
Johnson & Johnson seeks FDA approval for its ulcerative colitis treatment
|
| Nov 22 |
Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and others
|
| Nov 22 |
Johnson & Johnson seeks U.S. FDA approval for subcutaneous induction regimen of TREMFYA® (guselkumab) in ulcerative colitis, a first for an IL-23 inhibitor
|
| Nov 22 |
Johnson & Johnson (NYSE:JNJ) Stock Goes Ex-Dividend In Just Three Days
|
